1. Market Research
  2. > Healthcare
  3. > Medical Supply Market Trends
Asia Pacific Bioactive Wound Management Market to 2027- Covid-19 Impact and Regional Analysis by Product ; Application ; End User ], and Country

Asia Pacific Bioactive Wound Management Market to 2027- Covid-19 Impact and Regional Analysis by Product ; Application ; End User ], and Country

  • July 2020
  • 132 pages
  • ID: 5934763
  • Format: PDF
  • The Insight Partners
Up to $1000 off Until Aug 20th 2020


Table of Contents

Search Inside

The Asia Pacific bioactive wound management market is expected to reach US$ 676.54 million by 2027 from US$ 371.37 million in 2019. The market is estimated to grow at a CAGR of 7.9% during 2020-2027.The bioactive wound managementmarketis growing primarily due to the increasing prevalence of wounds and ulcers, and increasing healthcare expenditure in Asia Pacific. Factors such as high cost associated with wound care management, negatively impact the growth of the market. Additionally, government initiatives in research and development of healthcare sector and3D printing in wound care management are likely to fuel the growth of the bioactive wound management market during the forecast period.
Bioactive wound care management is a new trend in the healthcare sector.The bioactive wound care products are produced from artificial and natural sources, which have a fewer chance of infection, faster healing capacity and the risk of leaking is eliminated along with reducing pain and discomfort.

The bioactive wound care products are cost and time effective. The materials in the bioactive wound dressings include hydrocolloids, alginates, chitosan, keratin, and collagen.
The rise in the incidence of heath care expenditure is contributing to the growth of the market.Some countries of Asia Pacific have good healthcare expenditures on health measures.

Because of this, market scenarios in countries such as Japan and China have emerged in a profitable way.For example, per capita healthcare expenditures in purchasing power parity (PPP) in Japan increased from 2015 to 2016, from USD 4,436 per capita in purchasing power parity (PPP).

While India’s per capita public expenditure on health has doubled from Rs 621 per person from 2009 to 2010 to Rs 1,657 from 2017 to 2018, it still remains very low compared to other countries. The Indian government has aimed to raise expenditure on public health services to 2.5% of the country’s GDP by 2025. In 2018, the total expenditure on health care in China reached over 5.9 trillion yuan. The health expenditure in China has soared from under 500 billion yuan in 2000 to almost six trillion in 2018.
Chronic wounds often lead to complications, creating challenges for surgeons to manage such wounds.Active participation of government bodies and research universities promote advancements in the wound care field.

Several research organizations are engaged in the development of advanced wound care products.With the government policy supporting and encouraging domestic medical device innovation, some local manufacturers are growing stronger and competing with foreign suppliers.

Additionally, the Chinese government’s Made in China 2025 initiative to improve industry efficiency, product quality and brand reputation will further advance development of domestic medical device manufactures.This is likely to create growth opportunities during the forecast period.

Scientists from the Institute of Biophysics under the Chinese Academy of Sciences and the University of Science and Technology Beijing, created a new method to improve wound dressings by enhancing their blood coagulation and wound healing properties. Developed as a three-dimensional layered nano-fiber sponge, its elasticity increases the inter-facial interaction between the sponge and blood cells to control bleeding.
The outbreak of the COVID-19 pandemic has been first reported in China.The spread of infection has affected various Asian countries such as India, South Korea, Australia, Malaysia, and Singapore.

The countries have reported maximum deaths and laboratory diagnosed positive patients.The major focus has been shifted to treat COVID-19 affected patients and the production of personal equipment products.

On the other hand, Asian countries have a maximum number of burn cases.Countries such as India, Nepal, and Pakistan have ~1 million cases for burn wounds.

Therefore, the outbreak of the COVID-19 pandemic is estimated to negatively impact the bioactive wound management market.
In terms of product, the alginates accounted for the highest share in 2019.The growth of this segment is attributed to the increasing need for efficient and cost-effective wound management, availability of wide range of products in the market, and increasing adoption of bioactive treatment of chronic wounds.

However, the bioengineered skin substitutes segment is expected to grow with the highest growth rate during the forecast period, owing to its acceptance in a wide range of chronic wounds treatment, due to its faster healing and reduced infection properties.
A few of the significant secondary sources associated with the Asia Pacificbioactive wound managementmarket report are the World Health Organization (WHO), Australian Wound Management Association (AWMA), Australian Association of Practice Management, International Diabetes Federation, National Center for Biotechnology Information, and among others.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off


  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on